Given that IBD-associated aberrant RPS6KA2 methylation occurs within the gene body at a region with dense CpG content, and that no difference was seen in RPS6KA2 gene expression, the functional relevance of this finding may be difficult to delineate. The gene discussed is RPS6KA2; the disease is inflammatory bowel disease.